201 related articles for article (PubMed ID: 10846063)
1. The intracytoplasmic domain of the Env transmembrane protein is a locus for attenuation of simian immunodeficiency virus SIVmac in rhesus macaques.
Shacklett BL; Weber CJ; Shaw KE; Keddie EM; Gardner MB; Sonigo P; Luciw PA
J Virol; 2000 Jul; 74(13):5836-44. PubMed ID: 10846063
[TBL] [Abstract][Full Text] [Related]
2. Live, attenuated simian immunodeficiency virus SIVmac-M4, with point mutations in the Env transmembrane protein intracytoplasmic domain, provides partial protection from mucosal challenge with pathogenic SIVmac251.
Shacklett BL; Shaw KE; Adamson LA; Wilkens DT; Cox CA; Montefiori DC; Gardner MB; Sonigo P; Luciw PA
J Virol; 2002 Nov; 76(22):11365-78. PubMed ID: 12388697
[TBL] [Abstract][Full Text] [Related]
3. Importance of the intracytoplasmic domain of the simian immunodeficiency virus (SIV) envelope glycoprotein for pathogenesis.
Luciw PA; Shaw KE; Shacklett BL; Marthas ML
Virology; 1998 Dec; 252(1):9-16. PubMed ID: 9875311
[TBL] [Abstract][Full Text] [Related]
4. Evidence against extracellular exposure of a highly immunogenic region in the C-terminal domain of the simian immunodeficiency virus gp41 transmembrane protein.
Postler TS; Martinez-Navio JM; Yuste E; Desrosiers RC
J Virol; 2012 Jan; 86(2):1145-57. PubMed ID: 22072749
[TBL] [Abstract][Full Text] [Related]
5.
Martins MA; Tully DC; Pedreño-Lopez N; von Bredow B; Pauthner MG; Shin YC; Yuan M; Lima NS; Bean DJ; Gonzalez-Nieto L; Domingues A; Gutman MJ; Maxwell HS; Magnani DM; Ricciardi MJ; Bailey VK; Altman JD; Burton DR; Ejima K; Allison DB; Evans DT; Rakasz EG; Parks CL; Bonaldo MC; Capuano S; Lifson JD; Desrosiers RC; Allen TM; Watkins DI
J Virol; 2018 Aug; 92(16):. PubMed ID: 29875239
[TBL] [Abstract][Full Text] [Related]
6. Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac.
Marthas ML; Ramos RA; Lohman BL; Van Rompay KK; Unger RE; Miller CJ; Banapour B; Pedersen NC; Luciw PA
J Virol; 1993 Oct; 67(10):6047-55. PubMed ID: 8371353
[TBL] [Abstract][Full Text] [Related]
7. Chronology of genetic changes in the vpu, env, and Nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques.
McCormick-Davis C; Zhao LJ; Mukherjee S; Leung K; Sheffer D; Joag SV; Narayan O; Stephens EB
Virology; 1998 Sep; 248(2):275-83. PubMed ID: 9721236
[TBL] [Abstract][Full Text] [Related]
8. Persistent infection of rhesus macaques by the rev-independent Nef(-) simian immunodeficiency virus SIVmac239: replication kinetics and genomic stability.
von Gegerfelt AS; Liska V; Ray NB; McClure HM; Ruprecht RM; Felber BK
J Virol; 1999 Jul; 73(7):6159-65. PubMed ID: 10364376
[TBL] [Abstract][Full Text] [Related]
9. An epitope on the surface envelope glycoprotein (gp130) of simian immunodeficiency virus (SIVmac) involved in viral neutralization and T cell activation.
Torres JV; Malley A; Banapour B; Anderson DE; Axthelm MK; Gardner MB; Benjamini E
AIDS Res Hum Retroviruses; 1993 May; 9(5):423-30. PubMed ID: 7686386
[TBL] [Abstract][Full Text] [Related]
10. A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.
Demberg T; Florese RH; Heath MJ; Larsen K; Kalisz I; Kalyanaraman VS; Lee EM; Pal R; Venzon D; Grant R; Patterson LJ; Korioth-Schmitz B; Buzby A; Dombagoda D; Montefiori DC; Letvin NL; Cafaro A; Ensoli B; Robert-Guroff M
J Virol; 2007 Apr; 81(7):3414-27. PubMed ID: 17229693
[TBL] [Abstract][Full Text] [Related]
11. Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants.
Rud EW; Cranage M; Yon J; Quirk J; Ogilvie L; Cook N; Webster S; Dennis M; Clarke BE
J Gen Virol; 1994 Mar; 75 ( Pt 3)():529-43. PubMed ID: 8126450
[TBL] [Abstract][Full Text] [Related]
12. Identification of viral determinants of macrophage tropism for simian immunodeficiency virus SIVmac.
Banapour B; Marthas ML; Ramos RA; Lohman BL; Unger RE; Gardner MB; Pedersen NC; Luciw PA
J Virol; 1991 Nov; 65(11):5798-805. PubMed ID: 1920617
[TBL] [Abstract][Full Text] [Related]
13. The simian immunodeficiency virus transmembrane protein is poorly immunogenic in inactivated virus vaccine.
Cranage MP; McBride BW; Rud EW
Vaccine; 1995 Jul; 13(10):895-900. PubMed ID: 7483761
[TBL] [Abstract][Full Text] [Related]
14. SIV/HIV Nef recombinant virus (SHIVnef) produces simian AIDS in rhesus macaques.
Mandell CP; Reyes RA; Cho K; Sawai ET; Fang AL; Schmidt KA; Luciw PA
Virology; 1999 Dec; 265(2):235-51. PubMed ID: 10600596
[TBL] [Abstract][Full Text] [Related]
15. Elite Control, Gut CD4 T Cell Sparing, and Enhanced Mucosal T Cell Responses in Macaca nemestrina Infected by a Simian Immunodeficiency Virus Lacking a gp41 Trafficking Motif.
Breed MW; Elser SE; Torben W; Jordan AP; Aye PP; Midkiff C; Schiro F; Sugimoto C; Alvarez-Hernandez X; Blair RV; Somasunderam A; Utay NS; Kuroda MJ; Pahar B; Wiseman RW; O'Connor DH; LaBranche CC; Montefiori DC; Marsh M; Li Y; Piatak M; Lifson JD; Keele BF; Fultz PN; Lackner AA; Hoxie JA
J Virol; 2015 Oct; 89(20):10156-75. PubMed ID: 26223646
[TBL] [Abstract][Full Text] [Related]
16. A MHC class I B locus allele-restricted simian immunodeficiency virus envelope CTL epitope in rhesus monkeys.
Yasutomi Y; McAdam SN; Boyson JE; Piekarczyk MS; Watkins DI; Letvin NL
J Immunol; 1995 Mar; 154(5):2516-22. PubMed ID: 7532670
[TBL] [Abstract][Full Text] [Related]
17. Fatal immunopathogenesis by SIV/HIV-1 (SHIV) containing a variant form of the HIV-1SF33 env gene in juvenile and newborn rhesus macaques.
Luciw PA; Mandell CP; Himathongkham S; Li J; Low TA; Schmidt KA; Shaw KE; Cheng-Mayer C
Virology; 1999 Oct; 263(1):112-27. PubMed ID: 10544087
[TBL] [Abstract][Full Text] [Related]
18. Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine.
Qureshi H; Ma ZM; Huang Y; Hodge G; Thomas MA; DiPasquale J; DeSilva V; Fritts L; Bett AJ; Casimiro DR; Shiver JW; Robert-Guroff M; Robertson MN; McChesney MB; Gilbert PB; Miller CJ
J Virol; 2012 Feb; 86(4):2239-50. PubMed ID: 22156519
[TBL] [Abstract][Full Text] [Related]
19. Correlation between env V1/V2 region diversification and neutralizing antibodies during primary infection by simian immunodeficiency virus sm in rhesus macaques.
Rybarczyk BJ; Montefiori D; Johnson PR; West A; Johnston RE; Swanstrom R
J Virol; 2004 Apr; 78(7):3561-71. PubMed ID: 15016879
[TBL] [Abstract][Full Text] [Related]
20. Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication.
Kuwata T; Igarashi T; Ido E; Jin M; Mizuno A; Chen J; Hayami M
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2181-91. PubMed ID: 7561755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
